Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $3.52 billion. The enterprise value is $10.97 billion.
| Market Cap | 3.52B |
| Enterprise Value | 10.97B |
Important Dates
The last earnings date was Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | May 11, 2026 |
Share Statistics
Organon & Co. has 262.60 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 262.60M |
| Shares Outstanding | 262.60M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +1.05% |
| Owned by Insiders (%) | 0.50% |
| Owned by Institutions (%) | 77.17% |
| Float | 261.08M |
Valuation Ratios
The trailing PE ratio is 14.21 and the forward PE ratio is 3.87. Organon & Co.'s PEG ratio is 1.16.
| PE Ratio | 14.21 |
| Forward PE | 3.87 |
| PS Ratio | 0.57 |
| Forward PS | 0.57 |
| PB Ratio | 3.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.15 |
| P/OCF Ratio | 4.14 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.88, with an EV/FCF ratio of 16.06.
| EV / Earnings | 44.59 |
| EV / Sales | 1.78 |
| EV / EBITDA | 6.88 |
| EV / EBIT | 8.90 |
| EV / FCF | 16.06 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 9.49.
| Current Ratio | 1.97 |
| Quick Ratio | 1.00 |
| Debt / Equity | 9.49 |
| Debt / EBITDA | 5.15 |
| Debt / FCF | 12.55 |
| Interest Coverage | 2.51 |
Financial Efficiency
Return on equity (ROE) is 34.05% and return on invested capital (ROIC) is 6.51%.
| Return on Equity (ROE) | 34.05% |
| Return on Assets (ROA) | 5.89% |
| Return on Invested Capital (ROIC) | 6.51% |
| Return on Capital Employed (ROCE) | 11.74% |
| Weighted Average Cost of Capital (WACC) | 5.57% |
| Revenue Per Employee | $616,300 |
| Profits Per Employee | $24,600 |
| Employee Count | 10,000 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, Organon & Co. has paid $291.00 million in taxes.
| Income Tax | 291.00M |
| Effective Tax Rate | 54.19% |
Stock Price Statistics
The stock price has increased by +40.06% in the last 52 weeks. The beta is 1.54, so Organon & Co.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +40.06% |
| 50-Day Moving Average | 11.14 |
| 200-Day Moving Average | 8.93 |
| Relative Strength Index (RSI) | 73.44 |
| Average Volume (20 Days) | 3,248,670 |
Short Selling Information
The latest short interest is 20.04 million, so 7.63% of the outstanding shares have been sold short.
| Short Interest | 20.04M |
| Short Previous Month | 18.61M |
| Short % of Shares Out | 7.63% |
| Short % of Float | 7.67% |
| Short Ratio (days to cover) | 1.30 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.16 billion and earned $246.00 million in profits. Earnings per share was $0.94.
| Revenue | 6.16B |
| Gross Profit | 3.32B |
| Operating Income | 1.23B |
| Pretax Income | 537.00M |
| Net Income | 246.00M |
| EBITDA | 1.60B |
| EBIT | 1.23B |
| Earnings Per Share (EPS) | $0.94 |
Balance Sheet
The company has $1.12 billion in cash and $8.57 billion in debt, with a net cash position of -$7.45 billion or -$28.38 per share.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 8.57B |
| Net Cash | -7.45B |
| Net Cash Per Share | -$28.38 |
| Equity (Book Value) | 903.00M |
| Book Value Per Share | 3.44 |
| Working Capital | 2.43B |
Cash Flow
In the last 12 months, operating cash flow was $850.00 million and capital expenditures -$167.00 million, giving a free cash flow of $683.00 million.
| Operating Cash Flow | 850.00M |
| Capital Expenditures | -167.00M |
| Depreciation & Amortization | 363.00M |
| Net Borrowing | -487.00M |
| Free Cash Flow | 683.00M |
| FCF Per Share | $2.60 |
Margins
Gross margin is 53.84%, with operating and profit margins of 19.99% and 3.99%.
| Gross Margin | 53.84% |
| Operating Margin | 19.99% |
| Pretax Margin | 8.71% |
| Profit Margin | 3.99% |
| EBITDA Margin | 25.88% |
| EBIT Margin | 19.99% |
| FCF Margin | 11.08% |
Dividends & Yields
This stock pays an annual dividend of $0.08, which amounts to a dividend yield of 0.60%.
| Dividend Per Share | $0.08 |
| Dividend Yield | 0.60% |
| Dividend Growth (YoY) | -90.70% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.49% |
| Buyback Yield | -0.55% |
| Shareholder Yield | 0.05% |
| Earnings Yield | 7.00% |
| FCF Yield | 19.42% |
Analyst Forecast
The average price target for Organon & Co. is $11.25, which is -15.98% lower than the current price. The consensus rating is "Hold".
| Price Target | $11.25 |
| Price Target Difference | -15.98% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 0.28% |
| EPS Growth Forecast (3Y) | 1.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.26 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 6 |